Gross, G., Schofer, H., Wassilew, S., Friese, K., Timm, A., Guthoff, R., Pau, H.W., Malin, J.P., Wutzler, P. and Doerr, H.W. (2003) Herpes Zoster Guideline of the German Dermatology Society (DDG). Journal of Clinical Virology, 26, 277-293.
https://doi.org/10.1016/S1386-6532(03)00005-2

has been cited by the following article:

• TITLE: Clinical Study: Lotion Containing Propolis Special Extract GH 2002 0.5% vs. Placebo as On-Top Treatment of Herpes Zoster

  AUTHORS: Denisa Tomanova, Simona Holcova, M. Hladíková

  KEYWORDS: Herpes Zoster, Propolis, Controlled Clinical Trial

  JOURNAL NAME: Health, Vol.9 No.10, September 22, 2017

  ABSTRACT: Background: The aim of the clinical trial was to establish the contribution of propolis special extract GH 2002 as constituent of a lotion for the supportive treatment of Herpes zoster. Methods: 60 patients with diagnosed Herpes zoster were either treated with a propolis containing (n = 33) or an identical, but propolis-free lotion (n = 27) for 28 days, as an add-on therapy to oral antiviral treatment with aciclovir. Study parameters were the assessment of pain on a visual analogue scale, the assessment of the formation of new vesicles, and the safety of application of the preparation. Results: Improvement of pain was significantly better and quicker in the propolis lotion group (p